Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

187.38 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin Pressures
Clinical research company IQVIA (NYSE: IQV) announced better-than-expected revenue in Q2 CY2025, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2... 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Preview: IQVIA Hldgs's Earnings
Via Benzinga
Is IQVIA Hldgs Gaining or Losing Market Support?
Via Benzinga
Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?
It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings. 
Via Benzinga
Discover which S&P500 stocks are making waves on Tuesday.
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Why IQVIA (IQV) Stock Is Trading Up Today
Shares of clinical research company IQVIA (NYSE: IQV) jumped 15.9% in the morning session after the company reported second-quarter financial results that beat Wall Street expectations and raised its... 
Via StockStory
Topics Artificial Intelligence
Tuesday's session: gap up and gap down stock in the S&P500 index
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Iqvia Surges As 'Pluses' Outweigh 'Minuses' In Its Second-Quarter Report
Iqvia stock surged Tuesday after the clinical resource organization widely beat most second-quarter metrics. 
Via Investor's Business Daily
Topics Government
Tuesday's pre-market session: top gainers and losers in the S&P500 index
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
IQVIA (NYSE:IQV) Beats Q2 Sales Targets, Stock Soars
Clinical research company IQVIA (NYSE: IQV) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue... 
Via StockStory
IQVIA Reports Second-Quarter 2025 Results
From IQVIA Holdings Inc.
Via Business Wire
Earnings Scheduled For July 22, 2025
Via Benzinga
IQVIA Earnings: What To Look For From IQV
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 Low-Volatility Stocks We Approach with Caution
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Healthcare’s $110B AI Surge Is Picking Up Speed—and It’s Just the Beginning
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GEHC),(NASDAQ:WAY),(NYSE:CI),(NYSE:IQV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025
From IQVIA
Via Business Wire
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect.
President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. 
Via Investor's Business Daily
Topics Government
Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest... 
Via StockStory
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’
From IQVIA
Via Business Wire
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills
Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical workflows. 
Via Benzinga
IQVIA Launches New AI Agents for Life Sciences and Healthcare
From IQVIA
Via Business Wire
IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?
IQVIA stock may look ready for a breakout, but Adhishthana analysis reveals a complex time spiral that could last until 2030. 
Via Benzinga
Wednesday's session: top gainers and losers in the S&P500 index
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
IQVIA Announces Pricing of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.